JP5775657B2 - アミノ酸組成物を含有する疲労防止剤 - Google Patents

アミノ酸組成物を含有する疲労防止剤 Download PDF

Info

Publication number: JP5775657B2
Authority: JP; Japan
Prior art keywords: weight; parts; fatigue; amino acid; acid composition
Prior art date: 2006-06-13
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Fee Related

Application number

JP2008521230A

Other languages

English (en)

Japanese (ja)

Other versions

JPWO2007145239A1 (ja

Inventor

真人斎藤

宏行有田

土田　博

博土田

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Meiji Co Ltd

Original Assignee

Meiji Co Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2006-06-13

Filing date

2007-06-13

Publication date

2015-09-09

2007-06-13 Application filed by Meiji Co Ltd filed Critical Meiji Co Ltd

2007-06-13 Priority to JP2008521230A priority Critical patent/JP5775657B2/ja

2009-11-05 Publication of JPWO2007145239A1 publication Critical patent/JPWO2007145239A1/ja

2015-09-09 Application granted granted Critical

2015-09-09 Publication of JP5775657B2 publication Critical patent/JP5775657B2/ja

Status Expired - Fee Related legal-status Critical Current

2027-06-13 Anticipated expiration legal-status Critical

Links

150000001413 amino acids Chemical class 0.000 title claims description 86
239000000203 mixture Substances 0.000 title claims description 63
230000002929 anti-fatigue Effects 0.000 title claims description 40
239000003795 chemical substances by application Substances 0.000 title claims description 37
235000001014 amino acid Nutrition 0.000 claims description 85
229940024606 amino acid Drugs 0.000 claims description 85
210000005036 nerve Anatomy 0.000 claims description 25
206010049565 Muscle fatigue Diseases 0.000 claims description 23
DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims description 17
QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 claims description 15
235000004279 alanine Nutrition 0.000 claims description 15
HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 claims description 15
QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 claims description 14
KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims description 14
239000004472 Lysine Substances 0.000 claims description 14
ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 claims description 14
QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 claims description 14
ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 claims description 9
AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 claims description 9
ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 claims description 9
OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 claims description 9
KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 claims description 9
ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 claims description 9
AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 claims description 9
239000004473 Threonine Substances 0.000 claims description 9
KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 claims description 9
AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 claims description 9
229960000310 isoleucine Drugs 0.000 claims description 9
230000002265 prevention Effects 0.000 claims description 9
OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 claims description 9
239000004474 valine Substances 0.000 claims description 9
239000004475 Arginine Substances 0.000 claims description 8
ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims description 8
239000003112 inhibitor Substances 0.000 claims description 5
239000004480 active ingredient Substances 0.000 claims description 3
238000004519 manufacturing process Methods 0.000 claims 5
206010016256 fatigue Diseases 0.000 description 67
230000000694 effects Effects 0.000 description 25
235000013305 food Nutrition 0.000 description 16
239000008280 blood Substances 0.000 description 13
210000004369 blood Anatomy 0.000 description 13
238000005259 measurement Methods 0.000 description 13
230000006399 behavior Effects 0.000 description 10
238000000034 method Methods 0.000 description 10
239000000090 biomarker Substances 0.000 description 9
238000011156 evaluation Methods 0.000 description 9
239000000843 powder Substances 0.000 description 9
JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 8
208000019914 Mental Fatigue Diseases 0.000 description 7
238000011084 recovery Methods 0.000 description 7
102100037850 Interferon gamma Human genes 0.000 description 6
108010074328 Interferon-gamma Proteins 0.000 description 6
102000003814 Interleukin-10 Human genes 0.000 description 6
108090000174 Interleukin-10 Proteins 0.000 description 6
102000007544 Whey Proteins Human genes 0.000 description 6
108010046377 Whey Proteins Proteins 0.000 description 6
KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
229940076144 interleukin-10 Drugs 0.000 description 6
239000003921 oil Substances 0.000 description 6
235000019198 oils Nutrition 0.000 description 6
230000009471 action Effects 0.000 description 5
239000013589 supplement Substances 0.000 description 5
102000011632 Caseins Human genes 0.000 description 4
108010076119 Caseins Proteins 0.000 description 4
229920002472 Starch Polymers 0.000 description 4
229960000890 hydrocortisone Drugs 0.000 description 4
235000013336 milk Nutrition 0.000 description 4
239000008267 milk Substances 0.000 description 4
210000004080 milk Anatomy 0.000 description 4
239000000047 product Substances 0.000 description 4
239000000243 solution Substances 0.000 description 4
235000019698 starch Nutrition 0.000 description 4
238000012360 testing method Methods 0.000 description 4
241001465754 Metazoa Species 0.000 description 3
PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 3
239000005862 Whey Substances 0.000 description 3
235000013361 beverage Nutrition 0.000 description 3
230000000052 comparative effect Effects 0.000 description 3
239000003814 drug Substances 0.000 description 3
229910052500 inorganic mineral Inorganic materials 0.000 description 3
239000011707 mineral Substances 0.000 description 3
235000010755 mineral Nutrition 0.000 description 3
238000002360 preparation method Methods 0.000 description 3
235000018102 proteins Nutrition 0.000 description 3
102000004169 proteins and genes Human genes 0.000 description 3
108090000623 proteins and genes Proteins 0.000 description 3
229930003231 vitamin Natural products 0.000 description 3
235000013343 vitamin Nutrition 0.000 description 3
239000011782 vitamin Substances 0.000 description 3
229940088594 vitamin Drugs 0.000 description 3
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
235000021119 whey protein Nutrition 0.000 description 3
YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical group OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 2
QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical group OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
239000004471 Glycine Substances 0.000 description 2
XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
JDHILDINMRGULE-LURJTMIESA-N N(pros)-methyl-L-histidine Chemical compound CN1C=NC=C1C[C@H](N)C(O)=O JDHILDINMRGULE-LURJTMIESA-N 0.000 description 2
230000001154 acute effect Effects 0.000 description 2
230000000386 athletic effect Effects 0.000 description 2
UCMIRNVEIXFBKS-UHFFFAOYSA-N beta-alanine Chemical compound NCCC(O)=O UCMIRNVEIXFBKS-UHFFFAOYSA-N 0.000 description 2
230000037396 body weight Effects 0.000 description 2
210000004556 brain Anatomy 0.000 description 2
235000014633 carbohydrates Nutrition 0.000 description 2
150000001720 carbohydrates Chemical class 0.000 description 2
210000003169 central nervous system Anatomy 0.000 description 2
235000015165 citric acid Nutrition 0.000 description 2
ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 description 2
238000007796 conventional method Methods 0.000 description 2
230000003247 decreasing effect Effects 0.000 description 2
239000012153 distilled water Substances 0.000 description 2
229940079593 drug Drugs 0.000 description 2
238000001647 drug administration Methods 0.000 description 2
238000005516 engineering process Methods 0.000 description 2
239000000796 flavoring agent Substances 0.000 description 2
235000013376 functional food Nutrition 0.000 description 2
BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 description 2
239000008187 granular material Substances 0.000 description 2
229960003130 interferon gamma Drugs 0.000 description 2
JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
150000002632 lipids Chemical class 0.000 description 2
230000003387 muscular Effects 0.000 description 2
229960003512 nicotinic acid Drugs 0.000 description 2
235000001968 nicotinic acid Nutrition 0.000 description 2
239000011664 nicotinic acid Substances 0.000 description 2
235000016709 nutrition Nutrition 0.000 description 2
150000007524 organic acids Chemical class 0.000 description 2
239000002994 raw material Substances 0.000 description 2
235000020183 skimmed milk Nutrition 0.000 description 2
239000008107 starch Substances 0.000 description 2
239000000725 suspension Substances 0.000 description 2
XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 2
OGNSCSPNOLGXSM-UHFFFAOYSA-N (+/-)-DABA Natural products NCCC(N)C(O)=O OGNSCSPNOLGXSM-UHFFFAOYSA-N 0.000 description 1
BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
LUTLAXLNPLZCOF-UHFFFAOYSA-N 1-Methylhistidine Natural products OC(=O)C(N)(C)CC1=NC=CN1 LUTLAXLNPLZCOF-UHFFFAOYSA-N 0.000 description 1
FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
BRMWTNUJHUMWMS-UHFFFAOYSA-N 3-Methylhistidine Natural products CN1C=NC(CC(N)C(O)=O)=C1 BRMWTNUJHUMWMS-UHFFFAOYSA-N 0.000 description 1
102100030840 AT-rich interactive domain-containing protein 4B Human genes 0.000 description 1
GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
ACTIUHUUMQJHFO-UHFFFAOYSA-N Coenzym Q10 Natural products COC1=C(OC)C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UHFFFAOYSA-N 0.000 description 1
RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
229920001353 Dextrin Polymers 0.000 description 1
239000004375 Dextrin Substances 0.000 description 1
FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
102000002322 Egg Proteins Human genes 0.000 description 1
108010000912 Egg Proteins Proteins 0.000 description 1
SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
101000792935 Homo sapiens AT-rich interactive domain-containing protein 4B Proteins 0.000 description 1
DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
AHLPHDHHMVZTML-BYPYZUCNSA-N L-Ornithine Chemical compound NCCC[C@H](N)C(O)=O AHLPHDHHMVZTML-BYPYZUCNSA-N 0.000 description 1
150000008575 L-amino acids Chemical class 0.000 description 1
CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
LEVWYRKDKASIDU-IMJSIDKUSA-N L-cystine Chemical compound [O-]C(=O)[C@@H]([NH3+])CSSC[C@H]([NH3+])C([O-])=O LEVWYRKDKASIDU-IMJSIDKUSA-N 0.000 description 1
HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
102000004407 Lactalbumin Human genes 0.000 description 1
108090000942 Lactalbumin Proteins 0.000 description 1
108010063045 Lactoferrin Proteins 0.000 description 1
102000010445 Lactoferrin Human genes 0.000 description 1
102000008192 Lactoglobulins Human genes 0.000 description 1
108010060630 Lactoglobulins Proteins 0.000 description 1
GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Chemical group CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
108010070551 Meat Proteins Proteins 0.000 description 1
229920000881 Modified starch Polymers 0.000 description 1
241000699670 Mus sp. Species 0.000 description 1
SUHOOTKUPISOBE-UHFFFAOYSA-N O-phosphoethanolamine Chemical compound NCCOP(O)(O)=O SUHOOTKUPISOBE-UHFFFAOYSA-N 0.000 description 1
AHLPHDHHMVZTML-UHFFFAOYSA-N Orn-delta-NH2 Natural products NCCCC(N)C(O)=O AHLPHDHHMVZTML-UHFFFAOYSA-N 0.000 description 1
UTJLXEIPEHZYQJ-UHFFFAOYSA-N Ornithine Natural products OC(=O)C(C)CCCN UTJLXEIPEHZYQJ-UHFFFAOYSA-N 0.000 description 1
235000019482 Palm oil Nutrition 0.000 description 1
108010064851 Plant Proteins Proteins 0.000 description 1
ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
238000012356 Product development Methods 0.000 description 1
235000019484 Rapeseed oil Nutrition 0.000 description 1
235000019485 Safflower oil Nutrition 0.000 description 1
206010039509 Scab Diseases 0.000 description 1
BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
108010073771 Soybean Proteins Proteins 0.000 description 1
FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
229930003270 Vitamin B Chemical group 0.000 description 1
229930003268 Vitamin C Natural products 0.000 description 1
229930003316 Vitamin D Chemical group 0.000 description 1
QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Chemical group C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
229930003427 Vitamin E Natural products 0.000 description 1
229930003448 Vitamin K Chemical group 0.000 description 1
HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
239000002671 adjuvant Substances 0.000 description 1
FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical group OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
229910021529 ammonia Inorganic materials 0.000 description 1
239000010775 animal oil Substances 0.000 description 1
235000021120 animal protein Nutrition 0.000 description 1
235000003704 aspartic acid Nutrition 0.000 description 1
238000003287 bathing Methods 0.000 description 1
230000003542 behavioural effect Effects 0.000 description 1
SQVRNKJHWKZAKO-UHFFFAOYSA-N beta-N-Acetyl-D-neuraminic acid Natural products CC(=O)NC1C(O)CC(O)(C(O)=O)OC1C(O)C(O)CO SQVRNKJHWKZAKO-UHFFFAOYSA-N 0.000 description 1
229940000635 beta-alanine Drugs 0.000 description 1
OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
239000011230 binding agent Substances 0.000 description 1
229960002685 biotin Drugs 0.000 description 1
235000020958 biotin Nutrition 0.000 description 1
239000011616 biotin Substances 0.000 description 1
235000015895 biscuits Nutrition 0.000 description 1
235000008429 bread Nutrition 0.000 description 1
235000014121 butter Nutrition 0.000 description 1
239000011575 calcium Substances 0.000 description 1
229910052791 calcium Inorganic materials 0.000 description 1
239000002775 capsule Substances 0.000 description 1
150000001746 carotenes Chemical group 0.000 description 1
235000005473 carotenes Nutrition 0.000 description 1
239000005018 casein Substances 0.000 description 1
BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
235000021240 caseins Nutrition 0.000 description 1
230000001364 causal effect Effects 0.000 description 1
235000013351 cheese Nutrition 0.000 description 1
210000000991 chicken egg Anatomy 0.000 description 1
OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
229960001231 choline Drugs 0.000 description 1
229960004106 citric acid Drugs 0.000 description 1
239000011248 coating agent Substances 0.000 description 1
239000003240 coconut oil Substances 0.000 description 1
235000019864 coconut oil Nutrition 0.000 description 1
235000017471 coenzyme Q10 Nutrition 0.000 description 1
229940110767 coenzyme Q10 Drugs 0.000 description 1
239000003086 colorant Substances 0.000 description 1
150000001875 compounds Chemical class 0.000 description 1
235000008504 concentrate Nutrition 0.000 description 1
239000012141 concentrate Substances 0.000 description 1
230000010485 coping Effects 0.000 description 1
229910052802 copper Inorganic materials 0.000 description 1
239000010949 copper Substances 0.000 description 1
235000005687 corn oil Nutrition 0.000 description 1
239000002285 corn oil Substances 0.000 description 1
235000012495 crackers Nutrition 0.000 description 1
239000006071 cream Substances 0.000 description 1
235000015140 cultured milk Nutrition 0.000 description 1
229960003067 cystine Drugs 0.000 description 1
235000019425 dextrin Nutrition 0.000 description 1
238000003745 diagnosis Methods 0.000 description 1
235000013325 dietary fiber Nutrition 0.000 description 1
235000015872 dietary supplement Nutrition 0.000 description 1
239000007884 disintegrant Substances 0.000 description 1
239000002552 dosage form Substances 0.000 description 1
239000000839 emulsion Substances 0.000 description 1
230000037149 energy metabolism Effects 0.000 description 1
150000002148 esters Chemical class 0.000 description 1
150000002170 ethers Chemical class 0.000 description 1
235000021323 fish oil Nutrition 0.000 description 1
235000019634 flavors Nutrition 0.000 description 1
235000013373 food additive Nutrition 0.000 description 1
239000002778 food additive Substances 0.000 description 1
235000012041 food component Nutrition 0.000 description 1
235000013355 food flavoring agent Nutrition 0.000 description 1
239000005417 food ingredient Substances 0.000 description 1
235000013350 formula milk Nutrition 0.000 description 1
235000015203 fruit juice Nutrition 0.000 description 1
229960003692 gamma aminobutyric acid Drugs 0.000 description 1
WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
238000003304 gavage Methods 0.000 description 1
230000036541 health Effects 0.000 description 1
230000001900 immune effect Effects 0.000 description 1
230000028993 immune response Effects 0.000 description 1
238000002347 injection Methods 0.000 description 1
239000007924 injection Substances 0.000 description 1
229960000367 inositol Drugs 0.000 description 1
CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
238000007918 intramuscular administration Methods 0.000 description 1
238000001990 intravenous administration Methods 0.000 description 1
238000011835 investigation Methods 0.000 description 1
229910052742 iron Inorganic materials 0.000 description 1
CSSYQJWUGATIHM-IKGCZBKSSA-N l-phenylalanyl-l-lysyl-l-cysteinyl-l-arginyl-l-arginyl-l-tryptophyl-l-glutaminyl-l-tryptophyl-l-arginyl-l-methionyl-l-lysyl-l-lysyl-l-leucylglycyl-l-alanyl-l-prolyl-l-seryl-l-isoleucyl-l-threonyl-l-cysteinyl-l-valyl-l-arginyl-l-arginyl-l-alanyl-l-phenylal Chemical compound C([C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 CSSYQJWUGATIHM-IKGCZBKSSA-N 0.000 description 1
239000004310 lactic acid Substances 0.000 description 1
235000014655 lactic acid Nutrition 0.000 description 1
235000021242 lactoferrin Nutrition 0.000 description 1
229940078795 lactoferrin Drugs 0.000 description 1
239000008101 lactose Substances 0.000 description 1
239000007788 liquid Substances 0.000 description 1
235000021056 liquid food Nutrition 0.000 description 1
230000007774 longterm Effects 0.000 description 1
239000000314 lubricant Substances 0.000 description 1
239000011777 magnesium Substances 0.000 description 1
229910052749 magnesium Inorganic materials 0.000 description 1
239000001630 malic acid Substances 0.000 description 1
235000011090 malic acid Nutrition 0.000 description 1
WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
230000003340 mental effect Effects 0.000 description 1
229930182817 methionine Natural products 0.000 description 1
238000002156 mixing Methods 0.000 description 1
235000019426 modified starch Nutrition 0.000 description 1
210000003205 muscle Anatomy 0.000 description 1
229910052757 nitrogen Inorganic materials 0.000 description 1
230000000474 nursing effect Effects 0.000 description 1
230000035764 nutrition Effects 0.000 description 1
235000005985 organic acids Nutrition 0.000 description 1
150000007530 organic bases Chemical class 0.000 description 1
229960003104 ornithine Drugs 0.000 description 1
235000013808 oxidized starch Nutrition 0.000 description 1
239000002540 palm oil Substances 0.000 description 1
229940055726 pantothenic acid Drugs 0.000 description 1
235000019161 pantothenic acid Nutrition 0.000 description 1
239000011713 pantothenic acid Substances 0.000 description 1
239000006072 paste Substances 0.000 description 1
230000007170 pathology Effects 0.000 description 1
239000000546 pharmaceutical excipient Substances 0.000 description 1
150000003904 phospholipids Chemical class 0.000 description 1
SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Chemical group CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 description 1
239000002504 physiological saline solution Substances 0.000 description 1
235000013550 pizza Nutrition 0.000 description 1
235000021118 plant-derived protein Nutrition 0.000 description 1
230000036470 plasma concentration Effects 0.000 description 1
239000011591 potassium Substances 0.000 description 1
229910052700 potassium Inorganic materials 0.000 description 1
230000000384 rearing effect Effects 0.000 description 1
230000009467 reduction Effects 0.000 description 1
238000012827 research and development Methods 0.000 description 1
IKGXIBQEEMLURG-NVPNHPEKSA-N rutin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-NVPNHPEKSA-N 0.000 description 1
235000005713 safflower oil Nutrition 0.000 description 1
239000003813 safflower oil Substances 0.000 description 1
210000003296 saliva Anatomy 0.000 description 1
150000003839 salts Chemical class 0.000 description 1
CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
239000011669 selenium Substances 0.000 description 1
229910052711 selenium Inorganic materials 0.000 description 1
SQVRNKJHWKZAKO-OQPLDHBCSA-N sialic acid Chemical compound CC(=O)N[C@@H]1[C@@H](O)C[C@@](O)(C(O)=O)OC1[C@H](O)[C@H](O)CO SQVRNKJHWKZAKO-OQPLDHBCSA-N 0.000 description 1
239000011734 sodium Substances 0.000 description 1
229910052708 sodium Inorganic materials 0.000 description 1
235000014214 soft drink Nutrition 0.000 description 1
239000007787 solid Substances 0.000 description 1
239000002904 solvent Substances 0.000 description 1
229940001941 soy protein Drugs 0.000 description 1
241000894007 species Species 0.000 description 1
235000011496 sports drink Nutrition 0.000 description 1
238000007920 subcutaneous administration Methods 0.000 description 1
235000000346 sugar Nutrition 0.000 description 1
150000008163 sugars Chemical class 0.000 description 1
230000001502 supplementing effect Effects 0.000 description 1
239000000829 suppository Substances 0.000 description 1
239000000375 suspending agent Substances 0.000 description 1
208000024891 symptom Diseases 0.000 description 1
239000006188 syrup Substances 0.000 description 1
235000020357 syrup Nutrition 0.000 description 1
239000003826 tablet Substances 0.000 description 1
235000002906 tartaric acid Nutrition 0.000 description 1
239000011975 tartaric acid Substances 0.000 description 1
229960003080 taurine Drugs 0.000 description 1
210000001519 tissue Anatomy 0.000 description 1
229960004747 ubidecarenone Drugs 0.000 description 1
235000015112 vegetable and seed oil Nutrition 0.000 description 1
239000008158 vegetable oil Substances 0.000 description 1
235000019155 vitamin A Nutrition 0.000 description 1
239000011719 vitamin A Substances 0.000 description 1
NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Chemical group O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 1
235000019156 vitamin B Nutrition 0.000 description 1
239000011720 vitamin B Chemical group 0.000 description 1
235000019154 vitamin C Nutrition 0.000 description 1
239000011718 vitamin C Substances 0.000 description 1
235000019166 vitamin D Nutrition 0.000 description 1
239000011710 vitamin D Chemical group 0.000 description 1
150000003710 vitamin D derivatives Chemical group 0.000 description 1
235000019165 vitamin E Nutrition 0.000 description 1
229940046009 vitamin E Drugs 0.000 description 1
239000011709 vitamin E Substances 0.000 description 1
235000019168 vitamin K Nutrition 0.000 description 1
239000011712 vitamin K Chemical group 0.000 description 1
150000003721 vitamin K derivatives Chemical group 0.000 description 1
229940045997 vitamin a Drugs 0.000 description 1
229940046008 vitamin d Drugs 0.000 description 1
229940046010 vitamin k Drugs 0.000 description 1
235000008939 whole milk Nutrition 0.000 description 1
235000013618 yogurt Nutrition 0.000 description 1
239000011701 zinc Substances 0.000 description 1
229910052725 zinc Inorganic materials 0.000 description 1
235000021249 α-casein Nutrition 0.000 description 1
235000021241 α-lactalbumin Nutrition 0.000 description 1
235000021247 β-casein Nutrition 0.000 description 1
235000021246 κ-casein Nutrition 0.000 description 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/175—Amino acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/401—Proline; Derivatives thereof, e.g. captopril
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4172—Imidazole-alkanecarboxylic acids, e.g. histidine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Nutrition Science (AREA)
Neurology (AREA)
Diabetes (AREA)
Biomedical Technology (AREA)
Obesity (AREA)
Neurosurgery (AREA)
Hematology (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Mycology (AREA)
Food Science & Technology (AREA)
Polymers & Plastics (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Coloring Foods And Improving Nutritive Qualities (AREA)
Non-Alcoholic Beverages (AREA)

JP2008521230A 2006-06-13 2007-06-13 アミノ酸組成物を含有する疲労防止剤 Expired - Fee Related JP5775657B2 (ja)

Priority Applications (1)

Application Number	Priority Date	Filing Date	Title
JP2008521230A JP5775657B2 (ja)	2006-06-13	2007-06-13	アミノ酸組成物を含有する疲労防止剤

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
JP2006163683		2006-06-13
JP2006163683		2006-06-13
JP2008521230A JP5775657B2 (ja)	2006-06-13	2007-06-13	アミノ酸組成物を含有する疲労防止剤
PCT/JP2007/061879 WO2007145239A1 (fr)	2006-06-13	2007-06-13	Agent anti-fatigue contenant une composition d'acides aminés

Related Child Applications (1)

Application Number	Title	Priority Date	Filing Date
JP2015008128A Division JP2015120715A (ja)	2006-06-13	2015-01-19	アミノ酸組成物を含有する疲労防止剤

Publications (2)

Publication Number	Publication Date
JPWO2007145239A1 JPWO2007145239A1 (ja)	2009-11-05
JP5775657B2 true JP5775657B2 (ja)	2015-09-09

Family

ID=38831753

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
JP2008521230A Expired - Fee Related JP5775657B2 (ja)	2006-06-13	2007-06-13	アミノ酸組成物を含有する疲労防止剤
JP2015008128A Pending JP2015120715A (ja)	2006-06-13	2015-01-19	アミノ酸組成物を含有する疲労防止剤

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
JP2015008128A Pending JP2015120715A (ja)	2006-06-13	2015-01-19	アミノ酸組成物を含有する疲労防止剤

Country Status (4)

Country	Link
JP (2)	JP5775657B2 (fr)
KR (1)	KR20090019813A (fr)
CN (1)	CN101454000A (fr)
WO (1)	WO2007145239A1 (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
KR20090019813A (ko) *	2006-06-13	2009-02-25	메이지 데어리즈 코포레이션	아미노산 조성물을 함유하는 피로 방지제
CN104922115A (zh) *	2007-10-31	2015-09-23	株式会社明治	含有氨基酸组合物的抗疲劳剂
KR101325374B1 (ko)	2008-02-19	2013-11-08	가부시키가이샤 오츠까 세이야꾸 고죠	신체 기능의 회복에 유용한 경구 또는 경장 조성물
JPWO2010041647A1 (ja) *	2008-10-06	2012-03-08	株式会社明治	アミノ酸組成物を有効成分として含む持久力向上剤、疲労防止剤、又は疲労回復剤
JP6154322B2 (ja) *	2011-06-07	2017-06-28	味の素株式会社	アミノ酸組成物
JP2013060406A (ja) *	2011-09-15	2013-04-04	Kyowa Hakko Bio Co Ltd	脳疲労改善用経口剤
CN104509919A (zh) *	2013-09-30	2015-04-15	张自力	一种功能性营养素饮料
EP3066937B1 (fr) *	2013-10-09	2021-01-06	Ajinomoto Co., Inc.	Produit alimentaire contenant de l'histidine et son application
JP6496599B2 (ja) *	2014-06-13	2019-04-03	花王株式会社	筋タンパク質合成シグナル活性化剤
JP2016121194A (ja) *	2016-04-05	2016-07-07	協和発酵バイオ株式会社	脳疲労改善用経口剤
JP2019519603A (ja) *	2016-05-26	2019-07-11	普惠▲徳▼生技股▲分▼有限公司	乳酸を減少させるために使用する第一鉄アミノ酸キレートを含む組成物
MX2020001765A (es) *	2017-08-14	2020-07-29	Axcella Health Inc	Composiciones de aminoacidos para el tratamiento de enfermedad hepatica.
JP7275499B2 (ja)	2018-08-27	2023-05-18	味の素株式会社	脳機能改善用組成物
EP3991791A4 (fr) *	2019-06-25	2023-07-12	Ajinomoto Co., Inc.	Mélange d'acides aminés présentant une structure co-amorphe
KR102235563B1 (ko)	2020-08-26	2021-04-02	(주)이삼오구	고함량 아르기닌을 포함하는 피로회복 및 성기능 개선용 조성물
JP7414676B2 (ja) *	2020-09-14	2024-01-16	株式会社東芝	負荷推定装置、方法およびプログラム
JP7462127B1 (ja)	2023-08-16	2024-04-05	株式会社Healthy Body	筋肥大用組成物

Citations (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5026721A (en) *	1989-06-05	1991-06-25	Dudrick Stanley J	Amino acid nutritional supplement and regimen for enhancing physical performance through sound nutrition
JPH06336432A (ja) *	1993-05-28	1994-12-06	Rikagaku Kenkyusho	アドレナリン及びノルアドレナリン分泌促進組成物
JP2518692B2 (ja) *	1989-06-14	1996-07-24	理化学研究所	筋力持続剤，滋養強壮剤，輸液用剤，栄養補給剤，疲労回復剤及び乳酸生成調節剤
JPH09249556A (ja) *	1996-01-09	1997-09-22	Rikagaku Kenkyusho	アミノ酸組成物
WO2004028528A1 (fr) *	2002-09-30	2004-04-08	Riken	Compositions d'acides amines destinees a ameliorer les fonctions centrales
JP2004352696A (ja) *	2003-05-30	2004-12-16	Institute Of Physical & Chemical Research	アミノ酸組成物及び補液

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPH0725838A (ja) *	1993-05-13	1995-01-27	Yotsuba Yuka Kk	疲労の予防または回復のための経口投与剤
JP3617102B2 (ja) *	1995-01-27	2005-02-02	味の素株式会社	ヒト筋肉疲労の早期回復効果を有するアミノ酸栄養組成物
JP4280310B2 (ja) *	1995-08-10	2009-06-17	佐々木化学工業株式会社	アミノ酸組成剤
JP2000009717A (ja) *	1998-02-27	2000-01-14	Taisho Pharmaceut Co Ltd	滋養強壮効果の評価方法
JP2001226272A (ja) *	2000-02-18	2001-08-21	Zeria Pharmaceut Co Ltd	クエン酸及びローヤルゼリーを配合した内服液剤
JP3838038B2 (ja) *	2001-02-05	2006-10-25	株式会社豊田中央研究所	心身状態評価方法、商品又は環境の感性的品質の評価方法、評価用測定キット及び商品又は環境の品質表示方法
JP2003207495A (ja) *	2002-01-10	2003-07-25	Toyota Central Res & Dev Lab Inc	心理状態判定装置
AU2003271144A1 (en) *	2002-10-11	2004-05-04	Ajinomoto Co., Inc.	Food compositions for recovery from fatigue
GB0400031D0 (en) *	2004-01-03	2004-02-04	Univ Sheffield	Depression treatment
WO2005078448A1 (fr) *	2004-02-17	2005-08-25	Soiken Inc.	Appareil servant a evaluer le degre de fatigue, procede d'evaluation du degre de fatigue et utilisation de celui-ci
JP2005239579A (ja) *	2004-02-24	2005-09-08	Ajinomoto Co Inc	疲労回復剤及び疲労回復用食品
KR20090019813A (ko) *	2006-06-13	2009-02-25	메이지 데어리즈 코포레이션	아미노산 조성물을 함유하는 피로 방지제

2007
- 2007-06-13 KR KR1020087029275A patent/KR20090019813A/ko not_active Withdrawn
- 2007-06-13 WO PCT/JP2007/061879 patent/WO2007145239A1/fr not_active Ceased
- 2007-06-13 CN CNA2007800195101A patent/CN101454000A/zh active Pending
- 2007-06-13 JP JP2008521230A patent/JP5775657B2/ja not_active Expired - Fee Related
2015
- 2015-01-19 JP JP2015008128A patent/JP2015120715A/ja active Pending

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5026721A (en) *	1989-06-05	1991-06-25	Dudrick Stanley J	Amino acid nutritional supplement and regimen for enhancing physical performance through sound nutrition
JP2518692B2 (ja) *	1989-06-14	1996-07-24	理化学研究所	筋力持続剤，滋養強壮剤，輸液用剤，栄養補給剤，疲労回復剤及び乳酸生成調節剤
JPH06336432A (ja) *	1993-05-28	1994-12-06	Rikagaku Kenkyusho	アドレナリン及びノルアドレナリン分泌促進組成物
JPH09249556A (ja) *	1996-01-09	1997-09-22	Rikagaku Kenkyusho	アミノ酸組成物
WO2004028528A1 (fr) *	2002-09-30	2004-04-08	Riken	Compositions d'acides amines destinees a ameliorer les fonctions centrales
JP2004352696A (ja) *	2003-05-30	2004-12-16	Institute Of Physical & Chemical Research	アミノ酸組成物及び補液

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
JPN7012003890; 小林寛道: 'スポーツとアミノ酸サプリメント' 食の科学第２５５号, 1999, ｐ．９３-８８ *

Also Published As

Publication number	Publication date
CN101454000A (zh)	2009-06-10
JP2015120715A (ja)	2015-07-02
WO2007145239A1 (fr)	2007-12-21
JPWO2007145239A1 (ja)	2009-11-05
KR20090019813A (ko)	2009-02-25

Legal Events

Date	Code	Title	Description
2010-06-01	A621	Written request for application examination	Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20100531
2012-10-02	A131	Notification of reasons for refusal	Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20121002
2012-12-01	A521	Request for written amendment filed	Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20121130
2013-02-26	A02	Decision of refusal	Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20130226
2013-05-28	A521	Request for written amendment filed	Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20130527
2013-07-18	A911	Transfer to examiner for re-examination before appeal (zenchi)	Free format text: JAPANESE INTERMEDIATE CODE: A911 Effective date: 20130717
2013-08-12	A912	Re-examination (zenchi) completed and case transferred to appeal board	Free format text: JAPANESE INTERMEDIATE CODE: A912 Effective date: 20130809
2015-01-19	A521	Request for written amendment filed	Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20150119
2015-05-19	A521	Request for written amendment filed	Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20150518
2015-07-09	A61	First payment of annual fees (during grant procedure)	Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20150706
2015-07-10	R150	Certificate of patent or registration of utility model	Ref document number: 5775657 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150
2016-12-13	S531	Written request for registration of change of domicile	Free format text: JAPANESE INTERMEDIATE CODE: R313531
2016-12-21	R350	Written notification of registration of transfer	Free format text: JAPANESE INTERMEDIATE CODE: R350
2024-07-10	LAPS	Cancellation because of no payment of annual fees

Publication	Publication Date	Title
JP5775657B2 (ja)	2015-09-09	アミノ酸組成物を含有する疲労防止剤
JP5798648B2 (ja)	2015-10-21	アミノ酸組成物を含有する疲労防止剤
JP5574561B2 (ja)	2014-08-20	総合経腸栄養組成物
US20160058819A1 (en)	2016-03-03	Compositions of nutrition supplementation for nutritional deficiencies and method of use therefore
JP5173230B2 (ja)	2013-04-03	アミノ酸組成物及び飲食物
US20240268433A1 (en)	2024-08-15	Nutritional Compositions for Preserving Muscle Mass
JP2016102064A (ja)	2016-06-02	脂質代謝促進剤
JP6158565B2 (ja)	2017-07-05	筋タンパク質合成シグナル増強剤
WO2023022174A1 (fr)	2023-02-23	Composition alimentaire pour supprimer la fatigue musculaire et/ou une douleur musculaire soudaine
JP2019099498A (ja)	2019-06-24	脂質代謝促進のための組成物
JP2019099497A (ja)	2019-06-24	肝機能改善のための組成物
Komorowski et al.	2019	Inositol-Stabilized Arginine Silicate: A Novel Nitric Oxide-Boosting Ingredient for Sports Nutrition and Improved Cognition
HK1127730A (en)	2009-10-02	Anti-fatigue agent containing amino acid composition
JP2019099495A (ja)	2019-06-24	血圧降下促進のための組成物
CN119184312A (zh)	2024-12-27	具有改善的味道的营养组合物、其制备方法及用途
HK1144549A (en)	2011-02-25	Anti-fatigue agent comprising amino acid composition
JP2020200242A (ja)	2020-12-17	運動耐容能改善用組成物
CN112135531A (zh)	2020-12-25	终生干预期间超重或肥胖成年人的胰岛素控制
JP2019034894A (ja)	2019-03-07	脂質代謝促進のための組成物
JP2001231496A (ja)	2001-08-28	栄養組成物